Methylphenidate in Myotonic Dystrophy Type 1

NCT01421992 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

COMPLETED

Status

28

Enrollment

OTHER

Sponsor class

Conditions

Dystrophia Myotonica 1

Interventions

DRUG: Methylphenidate
DRUG: Placebo

Sponsor

Laval University